Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nephro Care IndiaNSE:NEPHROCARE +2.29%48 Pretax Margin % is 6.26% as of Mar. 2026, which is 26% below its 10-year median of 8.48. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Nephro Care India ranks better than 50.89% on this metric.
The historical rank and industry rank for Nephro Care India's Pretax Margin % or its related term are showing as below:
NSE:NEPHROCARE'
s Pretax Margin % Range Over the Past 10 Years
Min: 0.01 Med: 8.48 Max: 22.85
Current: 4.28
NSE:NEPHROCARE's Pretax Margin % is ranked better than 50.89% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: 4.065
vs NSE:NEPHROCARE: 4.28
Nephro Care India (NSE:NEPHROCARE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Nephro Care India Pretax Margin % Related Terms
Nephro Care India Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Nephro Care India's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEPHROCARE vs HCA, THC, EHC: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Nephro Care India's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Nephro Care India's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephro Care India (NSE:NEPHROCARE) has a Pretax Margin % of 6.26% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nephro Care India and its competitors. This is 26% below median its historical median of 8.48. Over the past decade, Nephro Care India's Pretax Margin % has ranged from 0.01 to 22.85. According to the industry distribution chart, Nephro Care India ranks #330 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 49.1%.
Is Nephro Care India's Pretax Margin % too high?
Nephro Care India's current Pretax Margin % of 6.26% is 26% below median its 10-year median of 8.48. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 22.85. The Healthcare Providers & Services industry median Pretax Margin % is 4.07. Nephro Care India's value of 6.26% is 54% above this industry median. Based on the distribution chart, Nephro Care India ranks #330 out of 672 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nephro Care India ranks #330 out of 672 companies for Pretax Margin %. This puts Nephro Care India in the upper half of its industry. The industry median Pretax Margin % is 4.07. Nephro Care India's value of 6.26% is 54% above this benchmark. Historically, Nephro Care India's own Pretax Margin % has ranged from 0.01 to 22.85 over the past decade. While the company's 10-year median is 8.48 vs. the industry median of 4.07, Nephro Care India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.07, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current Pretax Margin % of 6.26% is 54% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nephro Care India and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current Pretax Margin % is 6.26%, which is 26% below median its own 10-year median of 8.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Pretax Margin % of 6.26%. The current Pretax Margin % is 6.26%, which is 26% below median its 10-year median of 8.48 and 54% above the Healthcare Providers & Services industry median of 4.07. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Pretax Margin % is 6.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
